CIK: 0001056807 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value ($000): $3,995,809 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1,313,560 | 32.9% | $6.29 | +720.0% | CLASS A ORD | 61559X104 |
| RVMD | REVOLUTION MEDICINES INC | 5,981,212 | $171,541 | 4.3% | $25.19 | -4.6% | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 1,981,100 | $157,676 | 3.9% | $60.82 | +9.9% | COM | 05464T104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5,744,848 | $131,729 | 3.3% | $17.69 | -1.1% | COM | 74366E102 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $131,419 | 3.3% | $32.15 | -44.4% | COM | 501575104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 4,370,024 | $129,003 | 3.2% | $27.38 | +10.5% | COM | 604749101 |
| OLMA | OLEMA PHARMACEUTICALS INC | 9,135,893 | $128,177 | 3.2% | $37.66 | -64.3% | COM | 68062P106 |
| IONS | IONIS PHARMACEUTICALS INC | 2,428,613 | $122,864 | 3.1% | $39.42 | +21.5% | COM | 462222100 |
| KURA | KURA ONCOLOGY INC | 7,373,228 | $106,027 | 2.7% | $13.94 | -29.5% | COM | 50127T109 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,007,413 | $81,190 | 2.0% | $23.91 | -45.0% | COM | 35104E100 |
| GLPG | GALAPAGOS NV | 1,915,109 | $77,849 | 1.9% | $38.91 | — | SPON ADR | 36315X101 |
| — | MERUS N V | 2,752,420 | $75,692 | 1.9% | $28.37 | — | COM | N5749R100 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $75,435 | 1.9% | $19.56 | — | COM | 760273102 |
| ACIU | AC IMMUNE SA | 14,571,236 | $72,856 | 1.8% | $4.93 | -34.8% | SHS | H00263105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 8,774,570 | $69,846 | 1.7% | $5.47 | — | SPONSORED ADS | 152309100 |
| XOMA | XOMA CORP DEL | 3,633,743 | $67,224 | 1.7% | $15.57 | +5.8% | COM NEW | 98419J206 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,729,043 | $61,519 | 1.5% | $17.52 | +70.4% | COM | 45166A102 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $60,989 | 1.5% | $7.03 | +13.4% | COM | 98985Y108 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $60,321 | 1.5% | $18.98 | -62.8% | ORDINARY SHARES | G3855L106 |
| — | ESSA PHARMA INC | 8,748,629 | $57,741 | 1.4% | $3.65 | — | COM NEW | 29668H708 |
| JANX | JANUX THERAPEUTICS INC | 4,579,818 | $49,141 | 1.2% | $15.21 | -43.1% | COM | 47103J105 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $47,894 | 1.2% | $16.07 | — | COM | 88427A107 |
| — | 89BIO INC | 4,047,354 | $45,209 | 1.1% | $13.02 | — | COM | 282559103 |
| RLAY | RELAY THERAPEUTICS INC | 3,970,045 | $43,710 | 1.1% | $22.62 | -62.7% | COM | 75943R102 |
| XENE | XENON PHARMACEUTICALS INC | 890,072 | $40,997 | 1.0% | $28.96 | +22.0% | COM | 98420N105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,875,000 | $40,519 | 1.0% | $15.37 | 0.0% | COM | 87164F105 |
| TYRA | TYRA BIOSCIENCES INC | 2,739,595 | $37,943 | 0.9% | $16.11 | -19.6% | COM | 90240B106 |
| LXRX | LEXICON PHARMACEUTICALS INC | 24,435,632 | $37,387 | 0.9% | $2.49 | -52.3% | COM NEW | 528872302 |
| GPCR | STRUCTURE THERAPEUTICS INC | 812,988 | $33,137 | 0.8% | $23.79 | — | SPONSORED ADS | 86366E106 |
| CGEM | CULLINAN ONCOLOGY INC | 3,196,701 | $32,574 | 0.8% | $19.52 | -54.6% | COM | 230031106 |
| ANTX | AN2 THERAPEUTICS INC | 1,563,963 | $32,046 | 0.8% | $15.17 | +10.3% | COM | 037326105 |
| ANNX | ANNEXON INC | 7,000,000 | $31,780 | 0.8% | $2.47 | 0.0% | COM | 03589W102 |
| ROIV | ROIVANT SCIENCES LTD | 2,742,409 | $30,797 | 0.8% | $11.31 | -13.8% | SHS | G76279101 |
| SLN | SILENCE THERAPEUTICS PLC | 1,508,416 | $26,201 | 0.7% | $16.00 | — | ADS | 82686Q101 |
| — | ALLAKOS INC | 8,552,417 | $23,348 | 0.6% | $5.39 | — | COM | 01671P100 |
| — | GLYCOMIMETICS INC | 9,544,262 | $22,524 | 0.6% | $4.18 | — | COM | 38000Q102 |
| OVID | OVID THERAPEUTICS INC | 6,851,051 | $22,060 | 0.6% | $4.24 | -19.5% | COM | 690469101 |
| ENGN | ENGENE HOLDINGS INC | 2,251,037 | $20,777 | 0.5% | $10.40 | 0.0% | COM | 29286M105 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $19,328 | 0.5% | $23.30 | — | SPONSERED ADS | 13124Q106 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $17,429 | 0.4% | $2.68 | +70.9% | COM | 89854M101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $17,000 | 0.4% | $9.95 | -8.0% | ORDINARY SHARES | N62509109 |
| SYRE | SPYRE THERAPEUTICS INC | 687,080 | $14,786 | 0.4% | $13.78 | 0.0% | COM NEW | 00773J202 |
| — | SUTRO BIOPHARMA INC | 3,347,946 | $14,363 | 0.4% | $8.49 | — | COM | 869367102 |
| — | ITEOS THERAPEUTICS INC | 1,259,476 | $13,791 | 0.3% | $29.00 | — | COM | 46565G104 |
| VSTM | VERASTEM INC | 1,685,219 | $13,718 | 0.3% | $6.94 | +3.5% | COM NEW | 92337C203 |
| IMVT | IMMUNOVANT INC | 300,000 | $12,639 | 0.3% | $22.60 | +62.8% | COM | 45258J102 |
| VTGN | VISTAGEN THERAPEUTICS INC | 2,000,000 | $10,280 | 0.3% | $3.78 | 0.0% | COM | 92840H400 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,595,801 | $10,223 | 0.3% | $5.34 | -75.4% | COM | 23284F105 |
| — | IKENA ONCOLOGY INC | 4,769,164 | $9,395 | 0.2% | $12.00 | — | COM | 45175G108 |
| — | VERVE THERAPEUTICS INC | 650,000 | $9,061 | 0.2% | $34.35 | — | COM | 92539P101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 4,326,710 | $7,788 | 0.2% | $6.12 | -77.3% | COM | 28617K101 |
| — | SAB BIOTHERAPEUTICS INC | 9,178,282 | $6,310 | 0.2% | $0.69 | — | COM | 78397T103 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $6,130 | 0.2% | $9.10 | — | COM | 92673K108 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $5,448 | 0.1% | $2.37 | — | COM | 171757107 |
| — | RAIN ONCOLOGY INC | 3,526,729 | $4,232 | 0.1% | $13.68 | — | COM | 75082Q105 |
| DCTH | DELCATH SYS INC | 976,149 | $4,061 | 0.1% | $6.27 | -47.8% | COM NEW | 24661P807 |
| — | PIERIS PHARMACEUTICALS INC | 20,609,863 | $3,751 | 0.1% | $0.87 | — | COM | 720795103 |
| — | KRONOS BIO INC | 2,905,043 | $3,631 | 0.1% | $1.71 | — | COM | 50107A104 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $3,390 | 0.1% | $1.29 | — | SHS | H57830103 |
| IVA | INVENTIVA SA | 686,040 | $3,073 | 0.1% | $13.70 | — | ADS | 46124U107 |
| — | FORTE BIOSCIENCES INC | 2,982,105 | $2,450 | 0.1% | $0.66 | — | COM | 34962G109 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $2,413 | 0.1% | $5.07 | -71.2% | COM | 221015100 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $2,060 | 0.1% | $8.50 | — | COM | 92765F108 |
| — | MOLECULAR TEMPLATES INC | 532,038 | $1,969 | 0.0% | $6.32 | — | COM NEW | 608550208 |
| — | UNICYCIVE THERAPEUTICS INC | 2,118,139 | $1,838 | 0.0% | $0.86 | — | COM | 90466Y103 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $1,764 | 0.0% | $19.71 | — | ADS | 60853G106 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $1,242 | 0.0% | $10.15 | — | COM | 28623U101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $548 | 0.0% | $3.65 | — | SPON ADS NEW | 04522R200 |
| RZLT | REZOLUTE INC | 190,815 | $189 | 0.0% | $19.25 | -95.2% | COM NEW | 76200L309 |